Novartis AG, the Swiss drugmaker, agreed to help produce the Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE, boosting efforts to meet demand amid concerns about supply constraints.
Production is due to begin in the second quarter, with estimated delivery in the third quarter, according to a statement from the company on Friday. The pharma giant will rely on manufacturing facilities at a site in Stein, Switzerland.
Chief Executive Officer Vas Narasimhan told Bloomberg on Thursday that Novartis was in conversations with a range of companies to help produce coronavirus vaccines or treatments as the industry mobilizes ...
